Evidence map›Paper›PMID 40942024›Full record

ReviewMolecules (Basel, Switzerland)2025

Aged Garlic Extract and Its Bioactive Molecules S-Allyl-Cysteine and S1-Propenyl-Cysteine: A Review Focusing on Evidences Supporting Their Use for Mitigating the Effects of Cigarette Smoking.

Roberto Gambari, Alessia Finotti

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Roberto GambariDepartment of Life Sciences and Biotechnology, Ferrara University, I-44121 Ferrara, Italy.ORCID 0000-0001-9205-6033
Alessia FinottiDepartment of Life Sciences and Biotechnology, Ferrara University, I-44121 Ferrara, Italy.ORCID 0000-0002-7638-515X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the major social issues worldwide is tobacco dependency and cigarette smoking (CS) abuse. Given the significant impact of cigarette smoking on human health and diseases, extensive tobacco use and cigarette smoking abuse are certainly a form of drug addiction and should be considered a serious threat to human health. Notably, healthcare spending attributable to cigarette smoking is very high. In this regard, a significant number of biomolecules of natural origin have been described as capable of mitigating the adverse effects of cigarette smoking. In this review, (a) we discuss the impact that the habit of smoking tobacco has on human health and (b) we describe products of natural origin capable of mitigating the effects of cigarette smoke. The conclusion of this review article is that the available information strongly indicates a possible use of the anti-inflammatory aged garlic extract (AGE) and its bioactive components for mitigating the detrimental effects of cigarette smoke on human tissues. The key reasons for proposing this application are that AGE and its key components S-allyl-cysteine and S1-propenyl-cysteine are potent anti-inflammatory agents, bind to Toll-like Receptor-4, inhibit Nuclear Factor-κB, inhibit the expression of pro-inflammatory genes, revert apoptosis induced by cigarette smoke in several cellular model systems and are strong inhibitors of Reactive Oxygen Species (ROS) formation.

Indexed as

Cigarette SmokingCysteineGarlicPlant ExtractsAnimalsAnti-Inflammatory AgentsHumansAnti-Inflammatory AgentsCysteinePlant ExtractsS-allylcysteineaged garlic extractcigarette smokeinflammationnatural products

Identifiers

PMID40942024
PMCPMC12430746

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.